logo
Riding that wellness trend to a healthier Malaysia

Riding that wellness trend to a healthier Malaysia

The Star26-05-2025

Walk into any Malaysian pharmacy, scroll through social media, or spend five minutes at a weekend market, and you'll see it: the wellness wave.
Herbal teas promising 'natural detox', fitness trackers counting every step, yoga mats slung over shoulders like badges of honour, etc.
From the United States to South Korea to the Middle East – and now in Malaysia – people are becoming more proactive about their health, and much of that action is happening outside of hospitals and clinics.
This growing trend – often called consumer-driven wellness – is about everyday people taking charge of their health through diet, exercise, regular screenings and lifestyle tweaks.
In Malaysia, where chronic diseases are rising fast and public healthcare is under pressure, the impact could be huge.
But with every turmeric shot or 'miracle' supplement, there's a catch: not all wellness is backed by science, and some of it could do more harm than good.
A big business
Globally, wellness is big business.
Americans spend billions of dollars on health tech, supplements and boutique fitness classes.
In South Korea, wellness is sleek and high-tech – early screenings, personalised nutrition plans and 'biohacking' regimens are now part of mainstream life.
In the Middle East, especially in the United Arab Emirates and Saudi Arabia, government health campaigns are encouraging citizens to lose weight, eat better and be more active.
Boutique gyms and wellness retreats are popping up in cities like Dubai faster than you can say 'mindful meditation'.
Malaysia is starting to catch up.
Our cities are full of juice bars, organic grocers and fitness apps.
Instagram is bursting with local influencers touting 'clean eating' and morning workouts.
Even the government is encouraging healthier lifestyles through campaigns that aim to shift public attitudes from treatment to prevention.
This shift matters.
Malaysia is facing a serious health challenge.
Diabetes, high blood pressure and obesity are on the rise.
These diseases are expensive to treat, tough to manage and often avoidable.
Encouraging Malaysians to take better care of themselves before they get sick could save lives – and billions of ringgit.
Equal access needed
It's easy to see the appeal.
Why wait for a diagnosis when you can take small steps now to avoid getting sick in the first place?
Regular exercise, eating well, reducing stress and sleeping enough – these are the unglamorous, but powerful tools that can dramatically reduce your risk of major illnesses.
Financially, the benefits are just as clear.
Hospital bills, medication and lost productivity cost both individuals and the country huge amounts every year.
A study from the Health Ministry estimated that chronic diseases may cost Malaysia more than RM10bil a year.
Prevention doesn't just help people live longer, it helps them stay out of hospital beds and in the workforce.
But here's the challenge: not everyone can afford gym memberships or organic food.
The wellness trend risks becoming an urban, middle-class privilege.
For those in rural areas or low-income households, staying healthy isn't always a matter of choice; it's about access, time and cost.
If Malaysia wants wellness to be more than a lifestyle trend, it has to make it accessible to everyone.
Keep informed
Malaysia's multicultural heritage has long embraced natural and traditional remedies.
Malay jamu, Chinese herbs and Indian Ayurvedic treatments have been part of family routines for generations.
Many of these practices can offer real benefits, especially when it comes to minor ailments or stress relief.
But today's wellness marketplace is different.
It's louder, flashier and not always honest.
The rise of 'healthfluencers' on social media has led to a flood of bold claims: miracle pills that melt fat, supplements that 'cure' diabetes, detox kits that supposedly clean out your liver, etc.
Some of it is harmless, while some of it is useful, but some of it is dangerous.
Supplements may contain hidden drugs, interact with medications or give people false hope.
When someone chooses a fake cure over real treatment, the results can be deadly.
Regulators have tried to step in, but online sales and social media marketing make enforcement difficult.
The key is balance.
People shouldn't be discouraged from exploring traditional remedies or lifestyle changes, but they should have access to accurate information too.
That means educating the public, training healthcare professionals to talk about wellness without dismissing it, and holding scammers accountable.
Turning trends into strategy
The rise of consumer-driven health isn't a bad thing; in fact, it's exactly what Malaysia needs.
Our public hospitals are under pressure, our population is getting older, and lifestyle diseases are becoming more common.
Getting people to take care of their health before things go wrong is smart policy.
But to make it work, we need a strategy.
That means: Government support – e.g. incentives for health screenings, fitness programmes and nutritious food.
Better information – e.g. public education campaigns and regulation of health claims online.
Inclusive access – i.e. making sure wellness isn't just for the rich, but available in rural areas and low-income communities as well.
It also means a new mindset from doctors and patients alike.
People are no longer just passive patients; they're consumers, researchers and decision-makers.
Doctors need to engage with this reality, guide their patients through the noise, and work with – not against – this new wave of wellness.
Consumer-driven wellness isn't just a trend; it's a powerful shift in how we think about health.
Done right, it could help Malaysia become healthier, more resilient and less dependent on expensive treatments.
Done wrong, it could lead to more inequality, misinformation and false hope.
Wellness is good, but smart wellness – guided by science, grounded in reality, and open to all – is better.
Dr Helmy Haja Mydin is a consultant respiratory physician and Social & Economic Research Initiative chairman. For further information, email starhealth@thestar.com.my. The information provided is for educational and communication purposes only. The Star does not give any warranty on accuracy, completeness, functionality, usefulness or other assurances as to the content appearing in this column. The Star disclaims all responsibility for any losses, damage to property or personal injury suffered directly or indirectly from reliance on such information.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Kennedy's firing of independent CDC advisers undermines vaccine confidence, experts say
Kennedy's firing of independent CDC advisers undermines vaccine confidence, experts say

The Star

time36 minutes ago

  • The Star

Kennedy's firing of independent CDC advisers undermines vaccine confidence, experts say

A woman receives a booster dose of the COVID-19 vaccine at the Police hospital in Bangkok, Thailand, January 5, 2023. REUTERS/Athit Perawongmetha/File Photo CHICAGO (Reuters) -U.S. Health Secretary Robert F. Kennedy Jr.'s dismissal of an independent panel of experts citing the goal of restoring trust in vaccines could undermine confidence in those available now, putting Americans at risk of preventable infectious diseases, public health experts and others said on Monday. Kennedy, a longtime vaccine skeptic, said in a commentary published in the Wall Street Journal that he was firing all 17 members of the Advisory Committee for Immunization Practices (ACIP) at the Centers for Disease Control and Prevention "to re-establish public confidence in vaccine science.' The committee reviews vaccines approved by the U.S. Food and Drug Administration and makes recommendations to the CDC on their use. "I fear that there will be human lives lost here because of this," said Dr. Sean O'Leary, chair of the American Academy of Pediatrics' Committee on Infectious Diseases. "It is a special kind of irony that he is saying he is doing this to restore trust, given that he is, as an individual, more responsible for sowing distrust in vaccines than almost anyone I can name," O'Leary said. O'Leary said pediatricians have already been fielding calls from parents who are confused about conflicting announcements earlier this month narrowing the use of COVID-19 vaccines for healthy children and pregnant women. "This is only going to add to that," he said. A U.S. Department of Health and Human Services spokesman said the agency is prioritizing public health, evidence-based medicine, and restoring public confidence in vaccine science. The firing of the entire vaccine advisory committee comes just weeks before a scheduled public meeting in which advisers were expected to weigh in and vote on a number of decisions, including the 2025-26 COVID-19 vaccine boosters. The health agency said the committee will meet as scheduled on June 25-27, but it is unclear who would serve on that panel or how they have been vetted for conflicts of interest. The agency said it would replace them with new members currently under consideration. Fired ACIP member Noel Brewer, a professor of public health at the University of North Carolina, said it took about 18 months from the time he applied until he was serving as an ACIP member. Senate Minority Leader Chuck Schumer decried the changes. "Wiping out an entire panel of vaccine experts doesn't build trust — it shatters it, and worse, it sends a chilling message: that ideology matters more than evidence, and politics more than public health," he said in a statement. Former CDC Director Dr. Thomas Frieden called out Kennedy's "false claims" in the Wall Street Journal piece, saying the panel was rife with conflicts of interest. Most of the panel was appointed last year, the CDC website shows. "Make no mistake: PoliticizingtheACIPas Secretary Kennedy is doingwill undermine public trust under the guise of improving it." (Reporting by Julie Steenhuysen in Chicago; additional reporting by Mike Erman in New York; editing by Caroline Humer and Stephen Coates)

Harsheetaa dies in US due to multiple organ failure, sepsis
Harsheetaa dies in US due to multiple organ failure, sepsis

Sinar Daily

time6 hours ago

  • Sinar Daily

Harsheetaa dies in US due to multiple organ failure, sepsis

Harsheetaa, who studied at the same school where her parents teach, had been battling heterotaxy since birth. 10 Jun 2025 08:29pm Harsheetaa, who studied at the same school where her parents teach, had been battling heterotaxy since birth. - Photo source: R. Selva Ganapathy via Bernama KUALA LUMPUR - Eight-year-old S. Harsheetaa Sai, who had undergone heart surgery in the United States, passed away yesterday due to multiple organ failure and sepsis. The news was confirmed by her father, R. Selva Ganapathy, a teacher at Sekolah Jenis Kebangsaan Tamil Saraswathy in Sungai Buloh. Harsheetaa, who studied at the same school where her parents teach, had been battling heterotaxy since birth. She had been receiving treatment at Boston Children's Hospital, a leading medical centre in Massachusetts, since April. "Our hearts are heavy beyond words. Our brave little angel, Harsheetaa, who fought with all her strength, has now found peace in a place beyond pain and struggle. "She took her final breath at 1.10 am yesterday at Boston Children's Hospital. After putting up a courageous fight for days, her little body could no longer bear the pain,' said her father in a statement. Selva Ganapathy said Harsheetaa was surrounded by love, prayers, and the deepest care, adding that details of the final rites will be announced later. Meanwhile, Political Secretary to the Prime Minister, Datuk Ahmad Farhan Fauzi, shared his condolences with the family on Instagram. He also mentioned that the Prime Minister Datuk Seri Anwar Ibrahim had extended financial assistance to Harsheetaa's family, which he personally delivered during a visit to their home in Batu Caves, Selangor, on March 20. Heterotaxy is a rare congenital disorder in which internal organs develop in abnormal positions due to improper left-right patterning during fetal development. It commonly affects the heart, lungs, liver, spleen, and intestines, often leading to severe complications. Previously, Selva Ganapathy expressed his gratitude to Malaysians for raising RM1.5 million to fund his daughter's heart surgery. - BERNAMA

Of approved drugs and unapproved uses
Of approved drugs and unapproved uses

New Straits Times

time6 hours ago

  • New Straits Times

Of approved drugs and unapproved uses

NOT many Malaysians know what off-label drug prescriptions are, but Dr Kamini Shanmugaiah, a senior lecturer at the University Wollongong Australia KDU Penang University College writes in her op-ed in this newspaper that they may account for up to 50 per cent of all medication use, particularly in paediatric and geriatric patients. One won't be wrong in calling such practice a common use, controversial though it may be. If before we were worried about side effects of modern medicine, now we have to add off-label drug prescriptions to the list. But what exactly is off-label drug prescription? It is the unapproved use of approved drugs. The use of the cancer drug, methotrexate, for psoriasis is an example of unapproved use. Because of the lack of clinical trial data, the patients prescribed such medicines may be exposed to severe side effects, Kamini warns. If so, why resort to off-label prescriptions? The simple answer is there are no other drugs available or these drugs have not been tested on certain patients such as children and geriatric patients. Corrosive commerce plays a part, too. Pharmaceutical companies choose not to invest in clinical trials on such patients because they are not profit generators. No one expected capitalism to be compassionate, anyway. For the physicians who have to treat their patients even if there aren't any approved drugs for their ailments, it is one tightrope to walk. But so long as they follow guidelines issued by professional bodies such as the Malaysian Medical Council and act responsibly, they can keep medical negligence cases as far away as possible. Doctors serving in public hospitals would, however, need the approval of a few committees before they can prescribe off-label drugs. The idea is to ensure that such prescriptions are medically justified. Informed consent of patients — meaning physicians must disclose to patients any material risks posed by the drugs — is critical to avoid any legal liability. Surprisingly, for an old practice of using approved drugs for unapproved uses, there appears to be no Malaysian case law directly on point, as far as we can tell, which means a litigant must rely on general principles of medical negligence and malpractice. The court will obviously consider the standard of care appropriate for off-label prescriptions, which means the need for the physician to answer several questions. One, was the unapproved use based on guidelines issued by a medical body? Two, did the physician obtain the informed consent of the patient? Three, was the use in the best interest of the patient? Vulnerable patients such as children and the elderly have long been ignored by clinical studies conducted by pharmaceutical companies. Malaysia may not be able to do much about getting Big Pharma to be inclusive, but it can get local ones to do so. The European Union and the United States are using the legal regime to mandate paediatric trials. Malaysia must follow their lead and include geriatric trials as well. The EU and the US are right in moving up from guidelines to regulatory oversight to ensure patient safety. Malaysia must move up, too.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store